Exam 4 Material Flashcards
Define the following:
Aplastic Anemia
Aplastic Anemia: disorder characterized by cellular depletion and fatty replacement of the BM
Aplastic Anemia –
a. Most common cause
b. Five (5) secondary causes
c. Name of most common congenital disorder associated with aplastic anemia
a. Idiopathic – cause unknown
b.
1. Chemicals
2. Drugs
3. Radiation
4. Infections, esp. chronic
5. Myelophthistic replacement
c. Fanconi’s anemia
Aplastic anemia –
a. BM cellularity
b. Characteristic RBC morphology
c. Reticulocyte count
a. Hypocellular – upon BM aspiration, could have a “dry tap” (no cells aspirated)
b. Normocytic-Normochromic
c. Decreased to absent
Aplastic anemia –
a. CBC results
a. Mkd. decrease WBC count (< 1.5)
Mkd. decrease RBC count
Mkd. decrease Hgb. (< 7g/dL)
Mkd. decrease Plt. Count (20-60,000 cumm)
Aplastic anemia –
a. Treatment
a. Eliminate offending agent, if possible
“Support” therapy
• Antibiotics
• Blood products, esp. platelets and/or PRBCs
• Use of growth factors
Immunosuppressive therapy
Bone Marrow transplant
Define:
Hemoglobinopathy
Hemoglobinopathy: defect in the globin chain structure – typically a single point mutation that has altered the shape/structure/property of the globin chain (beta chain is most commonly affected)
Name the type of poikilocytosis that is found in most every hemoglobinopathy.
Target cells
Name the amino acid substitution found in sickle cell anemia.
On the beta chain, at the sixth (6th) position, glutamic acid is replaced by valine
List three factors contributing to the sickling process.
- Hypoxia – decrease of oxygen to the tissues
- Acidosis – decrease in pH
- Dehydration – decrease in plasma volume
Discuss the cause for each of the following clinical features of sickle cell anemia:
“Painful crises”:
“Acute chest syndrome”:
High risk of infections:
“Painful crises”: tissue damage precipitated by infection, fever, dehydration, exposure to extreme cold
“Acute chest syndrome”: pulmonary infarction – obstruction of blood flow, leading to tissue death due to lack of oxygen – can virtually occur in any organ (i.e. autosplenectomy – spleen becomes nonfunctional)
High risk of infections: spleen can’t aide in infections, due to the infarctions, resulting in decrease function and increase in infections
Compare and contrast sickle cell anemia and sickle cell trait according to:
Inheritance
Hgb. nomenclature
Solubility results
Hgb. Electrophoresis results
RBC morphology
Tx.
Inheritance
Sickle cell anemia:
Sickle cell trait:
Hgb. nomenclature
Sickle cell anemia: SS
Sickle cell trait: AS
Solubility results
Sickle cell anemia: Positive
Sickle cell trait: Positive
Hgb. Electrophoresis results
Sickle cell anemia: Migration to S and F – S > F (no A)
Sickle cell trait: Migration to S & A — A > S
RBC morphology
Sickle cell anemia: Targets + sickles, schistos, spheres, poly, H-J, Pap
Sickle cell trait: Slt. Targets, no sickles
Tx.
Sickle cell anemia: Adequate hydration, Pain relief (morphine), Antibiotics, Blood transfusion, Hydroxyurea to increase Hgb F, BM transplant, CRISPR
Sickle cell trait: No treatment
Discuss the Sickledex solubility (screening) test, including the:
Principle:
Reducing agent:
Causes for false positive results:
Causes for false negative results:
Principle: qualitative screening test for the presence of Hgb S – unable to differentiate sickle cell trait and sickle cell anemia
Reducing agent: sodium dithionite or sodium metabisulfite
Causes for false positive results:
• Proteinemia
• >18 g/dL HGB
• Other sickling HGBs
Causes for false negative results:
• Testing a newborn – the gamma-beta switch has not quite occurred; therefore, not enough Hgb S is present to be detectable
• < 7 g/dL HGB
• Multiple transfusions
Name the amino acid substitution found in Hemoglobin C disease.
On the beta chain, at the sixth (6th) position, glutamic acid is replaced by lysine
Compare and contrast Hemoglobin C disease and Hemoglobin C trait according to:
Clinical presentation
Hemoglobin nomenclature (AC versus CC)
Hemoglobin electrophoresis results
RBC morphology
Clinical presentation
Hemoglobin C disease: Mild hemolytic anemia, Splenomegaly
Hemoglobin C trait: Asymptomatic
Hemoglobin nomenclature (AC versus CC)
Hemoglobin C disease: CC
Hemoglobin C trait: AC
Hemoglobin electrophoresis results
Hemoglobin C disease: 100% C (no A)
Hemoglobin C trait: A > C
RBC morphology
Hemoglobin C disease: Targets + C crystals, poly
Hemoglobin C trait: Targets ONLY
Discuss Hemoglobin SC Disease according to:
Inheritance:
Clinical presentation:
Hemoglobin electrophoresis results:
RBC morphology:
Inheritance: Lysine substitution (C) from one parent – valine substitution (S) from the other parent
Clinical presentation: mild to moderately hemolytic anemia with painful crises
Hemoglobin electrophoresis results: S=C
RBC morphology: Targets + sickles, C crystals, S-C crystals, poly, H-J, Papp, nRBCs
Interpret cellulose acetate hemoglobin electrophoresis patterns for the following conditions:
cord blood
hemoglobin C disease
hemoglobin C trait
hemoglobin SC disease
sickle cell disease
sickle cell trait
Review electrophoresis slides for this information
Discuss Sickle Cell-Beta Thal according to:
Inheritance
Clinical presentation (Sickle-Beta0 Thal versus Sickle-Beta+ Thal)
Hemoglobin electrophoresis results (Sickle-Beta0 Thal versus Sickle-Beta+ Thal)
RBC morphology (Sickle-Beta0 Thal versus Sickle-Beta+ Thal)
Inheritance
Sickle-Beta0 Thal: Valine substitution (S) from one parent – B0 from the other parent
Sickle-Beta+ Thal: Valine substitution (S) from one parent – B+ from the other parent
Clinical presentation (Sickle-Beta0 Thal versus Sickle-Beta+ Thal)
Sickle-Beta0 Thal: Severe hemolytic anemia
Sickle-Beta+ Thal: Mild to Moderate anemia
Hemoglobin electrophoresis results (Sickle-Beta0 Thal versus Sickle-Beta+ Thal)
Sickle-Beta0 Thal: S > F > A2 (w/ no A)
Sickle-Beta+ Thal: S > A > F > A2
RBC morphology (Sickle-Beta0 Thal versus Sickle-Beta+ Thal)
Sickle-Beta0 Thal: Targets + sickles (usually), schistos, spheres, poly, H-J, Papp, nRBCs!!!
Sickle-Beta+ Thal: Same as Sickle-Beta0 Thal
List two ways that Hemoglobin D may be differentiated from Hemoglobin S … since they both migrate to the same point on cellulose acetate electrophoresis.
- Solubility testing (negative)
- Citrate acid electrophoresis
State the world’s third most common abnormal hemoglobin (behind Hgb S and Hgb C) and indicate the geographic area in which it commonly occurs.
Hemoglobin E – common in SE Asia
State the physiological mechanism for the predominant type of poikilocytosis found in the following hereditary hemolytic anemias:
Hereditary spherocytosis:
Hereditary elliptocytosis:
Hereditary stomatocytosis:
Hereditary spherocytosis: Decreased spectrin causes increased permeability of sodium into cell
Hereditary elliptocytosis: Decreased cholesterol in cell membrane causes hemoglobin to polarize to opposite ends – forming elliptocytes
Hereditary stomatocytosis: Defect in the sodium-potassium pump: results in abnormal slit-like pallor
Discuss Hereditary Spherocytosis according to:
Clinical presentation:
RBC indices:
RBC morphology:
Clinical presentation:
• Anemia
• Jaundice
• Splenomegaly
RBC indices:
• Hgb ~ 12g/dL
• MCV: normal
• MCHC: 36-38%
RBC morphology:
• Variable # of spheres
• Polychromasia
Discuss the osmotic fragility test with regard to:
Principle:
Conditions that show “increased osmotic fragility”:
Conditions that show “decreased osmotic fragility”:
Conditions that show “decreased resistance to hemolysis”:
Conditions that show “increased resistance to hemolysis”:
NaCl concentration when hemolysis should begin (in a normal person):
NaCl concentration when hemolysis should be completed (in a normal person):
Principle: A test to display the tendency of RBCs to break apart by adding them to a series of hypotonic salt solutions
Conditions that show “increased osmotic fragility”
Heredity spherocytosis
Conditions that show “decreased osmotic fragility”:
Hypochomic anemia
Sickle cell anemia
Any disease/condition with targets
Thalassemia
Conditions that show “decreased resistance to hemolysis”:
Heredity spherocytosis
Conditions that show “increased resistance to hemolysis”:
Hypochomic anemia
Sickle cell anemia
Any disease/condition with targets
Thalassemia
NaCl concentration when hemolysis should begin (in a normal person):
~ 0.45 – 0.50% NaCl
NaCl concentration when hemolysis should be completed (in a normal person):
~ 0.30 – 0.35% NaCl
State the type of poikilocytosis that demonstrates the greatest resistance to hemolysis.
Hypochomic anemia
Sickle cell anemia
Any disease/condition with targets
Thalassemia